Preoperative dobutamine stress echocardiographic findings and subsequent short-term adverse cardiac events afterorthotopic liver transplantation

Liver Transplantation

Volumn 14, Issue 6, 2008, Pages 886-892

  Umphrey, Lisa G ^a   Hurst, R Todd ^a   Eleid, Mackram F ^a   Lee, Kwan S ^a   Reuss, Christina S ^a   Hentz, Joseph G ^a   Vargas, Hugo E ^a   Appleton, Christopher P ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOBUTAMINE;

ADULT; ARTICLE; ASYSTOLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HOSPITAL DISCHARGE; HUMAN; INTRAOPERATIVE PERIOD; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; STRESS ECHOCARDIOGRAPHY;

ADRENERGIC BETA-AGONISTS; AGED; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; FEMALE; HEART RATE; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ROC CURVE; TREATMENT OUTCOME;

EID: 46049094820     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21495     Document Type: Article

References (24)

1. Plotkin JS, Scott VL, Pinna A, Dobsch BP, De Wolf AM, Kang Y. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg 1996;2:426-430.
2. Johnston SD, Morris JK, Cramb R, Gunson BK, Neuberger J. Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation 2002;73:901-906.
3. Guckelberger O, Mutzke F, Glanemann M, Neumann UP, Jonas S, Neuhaus R, et al. Validation of cardiovascular risk scores in a liver transplant population. Liver Transpl 2006;12:394-401.
4. Appleton CP, Hurst RT, Lee KS, Reuss C, Hentz JG. Longterm cardiovascular risk in the orthotopic liver transplant population [comment]. Liver Transpl 2006;12:352-355.
5. Murray KF, Carithers RL Jr. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology 2005;41:1407-1432.
6. Plevak DJ. Stress echocardiography identifies coronary artery disease in liver transplant candidates [comment]. Liver Transpl Surg 1998;4:337-339.
7. Plotkin JS, Benitez RM, Kuo PC, Njoku MJ, Ridge LA, Lim JW, et al. Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation [see comment]. Liver Transpl Surg 1998;4:253-257.
8. Williams K, Lewis JF, Davis G, Geiser EA. Dobutamine stress echocardiography in patients undergoing liver transplantation evaluation [see comment]. Transplantation 2000;69:2354-2356.
9. Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee To Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Coll Cardiol 2003;42:954-970.
10. Pellikka PA, Roger VL, Oh JK, Miller FA, Seward JB, Tajik AJ. Stress echocardiography. Part II. Dobutamine stress echocardiography: techniques, implementation, clinical applications, and correlations. [see comment]. Mayo Clinic Proc 1995;70:16-27.
11. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease [see comment]. Hepatology 2001;33:464-470.
12. Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001:7:567-580.
13. Sawada SG, Segar DS, Ryan T, Brown SE, Dohan AM, Williams R, et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 1991;83:1605-1614.
14. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction [see comment; published correction appears in J Am Coll Cardiol 2001;37:973]. J Am Coll Cardiol 2000; 36:959-969.
15. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee To Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2001;38:2101-2113.
16. Tsutsui JM, Mukherjee S, Elhendy A, Xie F, Lyden ER, O'Leary E, et al. Value of dobutamine stress myocardial contrast perfusion echocardiography in patients with advanced liver disease [see comment]. Liver Transpl 2006; 12:592-599.
17. Donovan CL, Marcovitz PA, Punch JD, Bach DS, Brown KA, Lucey MR, Armstrong WF. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation 1996; 61:1180-1188.
18. Findlay JY, Keegan MT, Pellikka PP, Rosen CB, Plevak DJ. Preoperative dobutamine stress echocardiography, intraoperative events, and intraoperative myocardial injury in liver transplantation. Transplant Proc 2005;37:2209-2213.
19. Ballal RS, Secknus MA, Mehta R, Kapadia S, Lauer MS, Marwick TH. Cardiac outcomes in coronary patients with submaximum dobutamine stress echocardiography. Am J Cardiol 1997;80:725-729.
20. Poldermans D, Fioretti PM, Forster T, Boersma E, Arnese M, du Bois NA, et al. Dobutamine-atropine stress echocardiography for assessment of perioperative and late cardiac risk in patients undergoing major vascular surgery. Eur J Vasc Surg 1994;8:286-293.
21. Pellikka PA, Roger VL, Oh JK, Seward JB, Tajik AJ. Safety of performing dobutamine stress echocardiography in patients with abdominal aortic aneurysm > or = 4 cm in diameter. Am J Cardiol 1996;77:413-416.
22. Krivokapich J, Child JS, Gerber RS, Lem V, Moser D. Prognostic usefulness of positive or negative exercise stress echocardiography for predicting coronary events in ensuing twelve months. Am J Cardiol 1993;71:646-651.
23. Chaowalit N, McCully RB, Callahan MJ, Mookadam F, Bailey KR, Pellikka PA. Outcomes after normal dobutamine stress echocardiography and predictors of adverse events: long-term follow-up of 3014 patients. Eur Heart J 2006;27:2039-2044.
24. Dresing TJ, Blacksonte EH, Pashkow FJ, Snader CE, Marwick TH, Lauer MS. Usefulness of impaired chronotropic response to exercise as a predictor of mortality, independent of the severity of coronary artery disease. Am J Cardiol 2000;86:602-609.